ValueAct returns to Valeant board, plans to raise stake

(Reuters) - Hedge fund ValueAct Capital said on Thursday it would return to the board of directors of Valeant Pharmaceuticals International Inc, which is pursuing a hostile takeover offer for...

from Reuters: Deals http://ift.tt/1vizAIL